525 related articles for article (PubMed ID: 32561148)
1. Treatment Considerations for COVID-19: A Critical Review of the Evidence (or Lack Thereof).
Vijayvargiya P; Esquer Garrigos Z; Castillo Almeida NE; Gurram PR; Stevens RW; Razonable RR
Mayo Clin Proc; 2020 Jul; 95(7):1454-1466. PubMed ID: 32561148
[TBL] [Abstract][Full Text] [Related]
2. Investigational Therapies for the Treatment of COVID-19: Updates from Ongoing Clinical Trials.
Abrams-Downey A; Saabiye J; Vidaurrazaga M
Eur Urol Focus; 2020 Sep; 6(5):1028-1031. PubMed ID: 32563675
[No Abstract] [Full Text] [Related]
3. Psychopharmacology of COVID-19.
Bilbul M; Paparone P; Kim AM; Mutalik S; Ernst CL
Psychosomatics; 2020; 61(5):411-427. PubMed ID: 32425246
[TBL] [Abstract][Full Text] [Related]
4. A Review of SARS-CoV-2 and the Ongoing Clinical Trials.
Tu YF; Chien CS; Yarmishyn AA; Lin YY; Luo YH; Lin YT; Lai WY; Yang DM; Chou SJ; Yang YP; Wang ML; Chiou SH
Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32290293
[TBL] [Abstract][Full Text] [Related]
5. An overview of the safety, clinical application and antiviral research of the COVID-19 therapeutics.
Wang D; Li Z; Liu Y
J Infect Public Health; 2020 Oct; 13(10):1405-1414. PubMed ID: 32684351
[TBL] [Abstract][Full Text] [Related]
6. Insights into antiviral mechanisms of remdesivir, lopinavir/ritonavir and chloroquine/hydroxychloroquine affecting the new SARS-CoV-2.
Uzunova K; Filipova E; Pavlova V; Vekov T
Biomed Pharmacother; 2020 Nov; 131():110668. PubMed ID: 32861965
[TBL] [Abstract][Full Text] [Related]
7. Treatment of SARS-CoV-2: How far have we reached?
Ahsan W; Javed S; Bratty MA; Alhazmi HA; Najmi A
Drug Discov Ther; 2020 May; 14(2):67-72. PubMed ID: 32336723
[TBL] [Abstract][Full Text] [Related]
8. Treatment of coronavirus disease 2019.
Hung IFN
Curr Opin HIV AIDS; 2020 Nov; 15(6):336-340. PubMed ID: 33002954
[TBL] [Abstract][Full Text] [Related]
9. Perspectives on the Early Quality of Evidence Guiding the Therapeutic Management of SARS-CoV-2: A Systematic Literature Review.
Subramanian K; Nalli A; Senthil V; Jain S; Nayak A; Bhat A
Adv Ther; 2020 Oct; 37(10):4107-4131. PubMed ID: 32809210
[TBL] [Abstract][Full Text] [Related]
10. Compounds with Therapeutic Potential against Novel Respiratory 2019 Coronavirus.
Martinez MA
Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32152082
[TBL] [Abstract][Full Text] [Related]
11. Some drugs for COVID-19.
Med Lett Drugs Ther; 2020 Apr; 62(1595):49-50. PubMed ID: 32324177
[No Abstract] [Full Text] [Related]
12. Characteristics of COVID-19 clinical trials registered with ClinicalTrials.gov: cross-sectional analysis.
Jones CW; Woodford AL; Platts-Mills TF
BMJ Open; 2020 Sep; 10(9):e041276. PubMed ID: 32948577
[TBL] [Abstract][Full Text] [Related]
13. Safety and Efficacy of Different Therapeutic Interventions on Prevention and Treatment of COVID-19.
Gyanwali P; Sharma S; Pant S; Koirala P; Adhikari K; Koirala J; Dhimal M
J Nepal Health Res Counc; 2020 Sep; 18(2):151-158. PubMed ID: 32969369
[TBL] [Abstract][Full Text] [Related]
14. Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review.
Sanders JM; Monogue ML; Jodlowski TZ; Cutrell JB
JAMA; 2020 May; 323(18):1824-1836. PubMed ID: 32282022
[TBL] [Abstract][Full Text] [Related]
15. Current status of potential therapeutic candidates for the COVID-19 crisis.
Zhang J; Xie B; Hashimoto K
Brain Behav Immun; 2020 Jul; 87():59-73. PubMed ID: 32334062
[TBL] [Abstract][Full Text] [Related]
16. SARS-CoV-2: Recent Reports on Antiviral Therapies Based on Lopinavir/Ritonavir, Darunavir/Umifenovir, Hydroxychloroquine, Remdesivir, Favipiravir and other Drugs for the Treatment of the New Coronavirus.
Costanzo M; De Giglio MAR; Roviello GN
Curr Med Chem; 2020; 27(27):4536-4541. PubMed ID: 32297571
[TBL] [Abstract][Full Text] [Related]
17. COVID-19: Main therapeutic options.
Hachfi W; Ben Lasfar N
Tunis Med; 2020 Apr; 98(4):299-303. PubMed ID: 32395792
[No Abstract] [Full Text] [Related]
18. Potential Antiviral Drugs for SARS-Cov-2 Treatment: Preclinical Findings and Ongoing Clinical Research.
Bimonte S; Crispo A; Amore A; Celentano E; Cuomo A; Cascella M
In Vivo; 2020 Jun; 34(3 Suppl):1597-1602. PubMed ID: 32503817
[TBL] [Abstract][Full Text] [Related]
19. Potential pharmacological agents for COVID-19.
Kotwani A; Gandra S
Indian J Public Health; 2020 Jun; 64(Supplement):S112-S116. PubMed ID: 32496239
[TBL] [Abstract][Full Text] [Related]
20. Potential strategies for combating COVID-19.
Shamim S; Khan M; Kharaba ZJ; Ijaz M; Murtaza G
Arch Virol; 2020 Nov; 165(11):2419-2438. PubMed ID: 32778950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
